General
Preferred name
PENCICLOVIR
Synonyms
BRL 39123 ()
VSA 671 ()
BRL-39123, VSA 671,NSC-759624 ()
BRL-39123 ()
Vectavir ()
NSC-759624 ()
Denavir ()
Fenistil ()
Sodium penciclovir ()
BRL-39123-D ()
PENCICLOVIR SODIUM ()
P&D ID
PD001690
CAS
39809-25-1
Tags
available
drug
prodrug
Approved by
FDA
First approval
1996
Drug indication
Human immunodeficiency virus infection
viral disease
Discovery agent
Coronavirus Disease 2019 (COVID-19)
Drug Status
approved
Max Phase
4.0
Probe control
Probe control not defined
Orthogonal probes
0
No orthogonal probes found
Similar probes
0
No structurally similar probes found
Structure formats
[[ format ]]
[[ compound[format === 'MOL' ? 'molblock' : format.toLowerCase()] ]]
Description
(extracted from source data)
PRICE
29
DESCRIPTION
Penciclovir (VSA 671) is a potent and selective anti-herpesvirus agent with EC50 values of 0.5, 0.8 ¦Ìg/ml for HSV-1 (HFEM), HSV-2 (MS), respectively. Penciclovir shows anti-herpesvirus activity with no-toxic. Penciclovir preventes mortality in mouse[1][2].
DESCRIPTION
Penciclovir (BRL 39123) is a Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor. In HSV infected cells, penciclovir is phosphorylated by viral thymidine kinase and subsequently converted by cellular kinases into the active metabolite, penciclovir triphosphate, which competitively inhibits viral HSV polymerase by blocking deoxyguanosine triphosphate substrate binding. As a result, herpes viral DNA synthesis and replication are selectively inhibited.
(TargetMol Bioactive Compound Library)
[[ p.pathway_name ]]
[[ compound.targets[tid].gene_name ]]
Cell lines
3
Organisms
8
Compound Sets
23
Axon Medchem Screening Library
Cayman Chemical Bioactives
ChEMBL Approved Drugs
ChEMBL Drugs
Drug Repurposing Hub
DrugBank
DrugBank Approved Drugs
DrugCentral
DrugCentral Approved Drugs
DrugMAP Approved Drugs
DrugMatrix
Enamine Bioactive Compounds
Enamine BioReference Compounds
MedChem Express Bioactive Compound Library
NCATS Inxight Approved Drugs
NIH Clinical Collections (NCC)
NPC Screening Collection
Prestwick Chemical Library
ReFrame library
Selleckchem Bioactive Compound Library
TargetMol Bioactive Compound Library
The Spectrum Collection
[[ a.name ]]
[[ ligand_id ]]
free of charge
External IDs
66
Molecular Weight
253.12
Hydrogen Bond Acceptors
7
Hydrogen Bond Donors
4
Rotatable Bonds
5
Ring Count
2
Aromatic Ring Count
2
cLogP
-1.31
TPSA
130.05
Fraction CSP3
0.5
Chiral centers
0.0
Largest ring
6.0
QED
0.52
Structural alerts
0
No structural alerts detected
Custom attributes
(extracted from source data)
Pathway
Microbiology/virology
Proteases/Proteasome
Anti-infection
Indication
cold sore
MOA
DNA directed DNA polymerase inhibitor
Target
Polymerase inhibitor
Antiviral
HSV
EBV
HCMV
HSV-1
HSV-2
VZV
Therapeutic Class
Antiviral Agents
Source data

